Talk Evidence - Z drugs, subclinical hypothyroidism and Drazen's dozen - a podcast by The BMJ
from 2019-06-25T16:58:44
This week on the podcast, (2.02) a listener asks, when we suggest something to stop, should we suggest an alternative instead?
(8.24) Helen tells us to stop putting people on treatment for subclinical hypothyroidism, but what does that mean for people who are already receiving thyroxine?(20.55) Carl has a black box warning about z drugs, and wonders what the alternative for sleep are.
(30.11) Finally the NEJM has published Jeff Drazen's dozen most influential papers - but not a systematic review amongst them. Cue the rant.Reading list:
Rapid rec on subclinical hypothyroidismhttps://www.bmj.com/content/365/bmj.l2006
Temporal trends in use of tests in UK primary care, 2000-15https://www.bmj.com/content/363/bmj.k4666
Black box warning for z-drugshttps://www.bmj.com/content/365/bmj.l2165
Drazen's dozen
https://cdn.nejm.org/pdf/Drazens-Dozen.pdf
Further episodes of Talk Evidence
Further podcasts by The BMJ
Website of The BMJ